These findings are in agreement with studies in breast cancers that showed that HER2 positive breast cancers are characterized by a higher number of lymphocytes and tumor associated macrophages, compared to HER2 negative breast cancer (26). This evidence concerns the gene ERBB2 and breast cancer.